Advertisement

Case Report | DOI: https://doi.org/10.31579/2834-8761/009

Pseudohyperparathyroidism

  • Mayer B. Davidson 1*
  • Ebony Funches 2

1 Charles R. Drew University, Los Angeles, California.

2 Venice Family Clinic, Venice, California.

*Corresponding Author: Mayer B. Davidson, Charles R. Drew University, Los Angeles, California.

Citation: Mayer B. Davidson and Ebony Funches. (2023), Pseudohyperparathyroidism, Clinical Endocrinology and Metabolism, 2(1); DOI: 10.31579/2834-8761/009

Copyright: © 2023, Mayer B. Davidson, this is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Received: 05 January 2023 | Accepted: 13 January 2023 | Published: 23 January 2023

Keywords: hyperparathyroidism; parathyroid gland; normocalcemic

Abstract

Objective – To describe a probably rare, but confusing, situation regarding the diagnosis of normocalcemic hyperparathyroidism.

Case Report: Following surgery for hyperparathyroidism, a parathyroid gland was transplanted into the patient’s lower right arm.  The patient was a poor historian and 4 years later when her care was transferred to another clinic, this information was not obtained.  Blood sampled from that arm revealed elevated parathyroid hormone and normal calcium levels.  Blood subsequently sampled from the other arm revealed normal parathyroid hormone and calcium levels.

Discussion: Although parathyroid gland transplantations have fallen out of favor because they often do not function either acutely or sustainably, this patient showed that some do continue to function and can confuse subsequent evaluations.

Conclusion: This case illustrates (once again) the importance of an accurate patient history.

Introduction

Normocalcemic hyperparathyroidism (NHPT), first defined and accepted by the 3rd International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism [1] with further refinements in the 4th Workshop [2] is characterized by persistently elevated parathyroid hormone (PTH) but normal serum calcium levels [3]. This diagnosis is one of exclusion after causes of secondary hyperparathyroidism have been excluded. These include vitamin D deficiency, calcium malabsorption, renal failure, certain medications (loop and thiazide diuretics, lithium, bisphosphonates, denosumab) and idiopathic hypercalciuria [3].  Finally, pseudohypoparathyroidism, a group of rare disorders with biochemical and clinical features of hypoparathyroidism but with target organ resistance to the effects of PTH, is also characterized by elevated levels of PTH and normocalcemia [4].  Most of these patients have an abnormality of the Gs protein or its downstream effector system.  NHPT is thought to represent early primary hyperparathyroidism before the serum calcium becomes elevated [5].

Case Presentation

The following patient represents a situation in which NHPT may be mistakenly diagnosed.  When this 61-year-old woman transferred her care to our Federally Qualified Health Center last year, she gave a history of surgery for hyperparathyroidism in 2017. No previous records were available but were requested.  Consequently, PTH and calcium levels were measured on September 4, 2020 (Table). The PTH level returned at 344 pg/ml. Suspecting a laboratory or reporting error, the test was repeated when the patient next returned to the clinic on April 6, 2021 and the value returned at 759 pg/ml.  Once again, previous records were requested and finally became available.  The surgical note revealed that a parathyroid gland had been transplanted in the lower right arm.  When queried, the patient responded that both samples had been obtained from the right arm. The third blood sampling on May 18, 2021 took place from the left arm and the PTH concentration was 37 pg/ml. Serum calcium levels were normal in all 3 blood samples in which PTH was measured.  The eGFR was normal and the 25 hydroxyvitamin D level was 22 ng/ml in the second blood test, a value that is not low according to the Institute of Medicine [6].

Date

PTH*

(pg/ml)

 

Calcium

(mg/dl)

eGFR

(ml/min/1.73 m2)

25-OH vitamin D

(ng/ml)

September 4, 2020

344

8.9

96

-

April 6, 2021

759

9.5

-

22

May 18, 2021

37

9.4

98

-

*Parathyroid hormone

Table: Patient’s Laboratory Values

Discussion

This patient represents a situation in which NHPT may be mistakenly diagnosed.  Although the possibility of calcium malabsorption and hypercalciuria were not pursued, the patient was not taking any of the drugs associated with secondary hyperparathyroidism and the eGFR was normal.  Furthermore, PTH levels in secondary hyperparathyroidism are not as high as this patient’s initially measured values.  These very high PTH concentrations may be seen in tertiary hyperparathyroidism but in this patient, the eGFR was normal.

Conclusion

This case illustrates the importance of an accurate history (not always available from the patient).  Specifically, if a parathyroid gland transplantation to one arm has occurred, the patient needs to be reminded to have the other arm sampled when PTH levels are ordered.  We have labelled this situation as “pseudohyperparathyroidism”.

References

Clinical Trials and Clinical Research: I am delighted to provide a testimonial for the peer review process, support from the editorial office, and the exceptional quality of the journal for my article entitled “Effect of Traditional Moxibustion in Assisting the Rehabilitation of Stroke Patients.” The peer review process for my article was rigorous and thorough, ensuring that only high-quality research is published in the journal. The reviewers provided valuable feedback and constructive criticism that greatly improved the clarity and scientific rigor of my study. Their expertise and attention to detail helped me refine my research methodology and strengthen the overall impact of my findings. I would also like to express my gratitude for the exceptional support I received from the editorial office throughout the publication process. The editorial team was prompt, professional, and highly responsive to all my queries and concerns. Their guidance and assistance were instrumental in navigating the submission and revision process, making it a seamless and efficient experience. Furthermore, I am impressed by the outstanding quality of the journal itself. The journal’s commitment to publishing cutting-edge research in the field of stroke rehabilitation is evident in the diverse range of articles it features. The journal consistently upholds rigorous scientific standards, ensuring that only the most impactful and innovative studies are published. This commitment to excellence has undoubtedly contributed to the journal’s reputation as a leading platform for stroke rehabilitation research. In conclusion, I am extremely satisfied with the peer review process, the support from the editorial office, and the overall quality of the journal for my article. I wholeheartedly recommend this journal to researchers and clinicians interested in stroke rehabilitation and related fields. The journal’s dedication to scientific rigor, coupled with the exceptional support provided by the editorial office, makes it an invaluable platform for disseminating research and advancing the field.

img

Dr Shiming Tang

Clinical Reviews and Case Reports, The comment form the peer-review were satisfactory. I will cements on the quality of the journal when I receive my hardback copy

img

Hameed khan